Top compounds associated with response to CH507-9B2.9


Feature Type Standardized
Nominal ANOVA
mRNA CD-437 CTRPv2 pan-cancer AAC 0.069 0.04
mRNA SKI-II CTRPv2 pan-cancer AAC 0.079 0.05
mRNA elocalcitol CTRPv2 pan-cancer AAC -0.074 0.05
mRNA ruxolitinib CTRPv2 pan-cancer AAC 0.074 0.05
mRNA SR-II-138A CTRPv2 pan-cancer AAC 0.067 0.05
mRNA momelotinib CTRPv2 pan-cancer AAC 0.074 0.05
mRNA TG-100-115 CTRPv2 pan-cancer AAC 0.078 0.05
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.063 0.05
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.076 0.05
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.075 0.05
Download CSV